Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InvivoCue is a Singapore-based biotechnology company that specializes in providing advanced humanized mouse models for preclinical drug development. Founded as a spin-off from the Agency for Science, Technology and Research (A*STAR), the company offers the HiMice platform, which features mice with reconstituted human immune systems or humanized livers. These models are designed to provide more predictive data for human clinical outcomes compared to traditional animal models, particularly in the fields of oncology, immunology, and infectious diseases. InvivoCue operates as a Contract Research Organization (CRO), offering services such as efficacy testing, safety profiling, and pharmacokinetics for a wide range of therapeutic modalities. By bridging the gap between laboratory research and clinical trials, the company helps pharmaceutical and biotech partners accelerate their drug discovery pipelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InvivoCue.